Featured Research

from universities, journals, and other organizations

Researchers Find How Two Cancer Genes Interact To Cause Malignancy

Date:
February 26, 1999
Source:
Duke University Medical Center
Summary:
Researchers at Duke University Medical Center have discovered how two cancer-causing genes can interact to transform normal cells into cancerous cells, adding further insight into the long-held theory that cancers require mutations in multiple genes.

DURHAM, N.C. -- Researchers at Duke University Medical Center have discovered how two cancer-causing genes can interact to transform normal cells into cancerous cells, adding further insight into the long-held theory that cancers require mutations in multiple genes.

Related Articles


In a paper published in the Feb. 26 issue of Molecular Cell, geneticist Joseph Nevins and his colleagues report details of the functional interaction between the proteins produced by two cancer-related genes, called "myc" and "ras."

Basically, the researchers discovered that mutated ras causes the protein from myc to accumulate in the cell, enhancing myc's growth-promoting abilities. If ras is not mutated, the myc growth-stimulating signal dies rapidly and cellular replication is controlled.

"The 'multi-hit' notion of cancer has been around for a while," said Nevins, a Howard Hughes Medical Institute Investigator at Duke. "In the mid 1980s scientists showed that if both myc and ras were mutated, the cells became cancerous. Until now there has been little mechanistic information as to how these two genes work together."

The researchers' report shows that the myc protein lasts five times longer than normal if ras is mutated. This information could eventually affect treatment and diagnosis of many cancers, including brain, colorectal and endometrial (uterine). Tumor cells with mutations in both myc and ras are likely to have an even more dramatic increase in the duration of the myc growth signal, Nevins said.

"The key to developing better therapeutics for cancer," said Nevins, "is using the information learned about interactions such as that of ras with myc to design drugs that interfere with these oncogenic processes." Like all so-called oncogenes, myc and ras perform important cell functions when normal, but act as accelerators to spur uncontrolled cell proliferation when mutated. In normal cells, the amount of protein produced by the myc gene increases to promote cell growth and then drops to prevent cells from multiplying further. Ras is important in transmitting signals through the cell.

In their experiments on normal cells, the researchers found that without mutated ras, half of the myc protein initially present was degraded within 10 minutes.

However, in cells with mutated ras, it took 50 minutes to degrade half of the myc protein. Myc protein's half-life is longer because the mutated ras protein interferes with the cell's natural degradation of myc protein, much like clogging a sink. As the myc protein accumulates, the cells continue to divide after they should have stopped.

"The myc protein is normally very short-lived, but a mutated ras can increase its stability," Nevins explained. "This is probably not the only way these two proteins and genes interact, but it is one way."

The researchers still are exploring the exact mechanism by which ras protein interferes with myc's degradation, as well as seeking other factors in the cell that control the stability of myc. More detailed knowledge could lead to new therapies, Nevins said.

"Understanding the precise mechanisms that regulate these activities opens the way to developing therapeutics that specifically target the abnormal function, leaving the normal functions alone," he said.

Other authors of the Molecular Cell study were Rosalie Sears and Gustavo Leone of Duke, and James DiGregori, formerly of Duke and now at the University of Colorado at Denver.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "Researchers Find How Two Cancer Genes Interact To Cause Malignancy." ScienceDaily. ScienceDaily, 26 February 1999. <www.sciencedaily.com/releases/1999/02/990226081253.htm>.
Duke University Medical Center. (1999, February 26). Researchers Find How Two Cancer Genes Interact To Cause Malignancy. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/1999/02/990226081253.htm
Duke University Medical Center. "Researchers Find How Two Cancer Genes Interact To Cause Malignancy." ScienceDaily. www.sciencedaily.com/releases/1999/02/990226081253.htm (accessed March 3, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 3, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins